Sun, Dec 1, 2024
Volume 10, Issue 4 (12-2022)
J. Pediatr. Rev 2022, 10(4): 341-348 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Mostofizadeh N, Najafi M, Hovsepian S, Hashemi Dehkordi E, Rostampour N, Hashemipour M. Prevalence of Insulin Injection-induced Lipodystrophy and Associated Risk Factors in Children and Adolescents With Type 1 Diabetes Mellitus. J. Pediatr. Rev 2022; 10 (4) :341-348
URL: http://jpr.mazums.ac.ir/article-1-437-en.html
URL: http://jpr.mazums.ac.ir/article-1-437-en.html
Neda Mostofizadeh1 
, Milad Najafi2 , Silva Hovsepian * 3, Elham Hashemi Dehkordi4 , Nousin Rostampour5 , Mahin Hashemipour1
, Milad Najafi2 , Silva Hovsepian * 3, Elham Hashemi Dehkordi4 , Nousin Rostampour5 , Mahin Hashemipour1
1- Department of Pediatric Endocrinology, Metabolic Liver Disease Research Center, Isfahan Endocrine and Metabolism Research Center, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
2- Department of Pediatric Endocrinology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
3- Department of Pediatric Endocrinology, Metabolic liver Disease Research Center, School of Medicine, Imam Hossien Children’s Hospital, Isfahan University of Medical Sciences, Isfahan, Iran. ,silvahovsepsecret@gmail.com
4- Department of Pediatric Endocrinology, Isfahan Endocrine and Metabolism Research Center, Child Growth and Development Research Center, Research Institute for Primordial Prevention of Non-communicable Disease, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
5- Department of Pediatric Endocrinology, Metabolic Liver Disease Research Center, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
2- Department of Pediatric Endocrinology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
3- Department of Pediatric Endocrinology, Metabolic liver Disease Research Center, School of Medicine, Imam Hossien Children’s Hospital, Isfahan University of Medical Sciences, Isfahan, Iran. ,
4- Department of Pediatric Endocrinology, Isfahan Endocrine and Metabolism Research Center, Child Growth and Development Research Center, Research Institute for Primordial Prevention of Non-communicable Disease, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
5- Department of Pediatric Endocrinology, Metabolic Liver Disease Research Center, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Abstract: (2432 Views)
Background: Lipodystrophy is the most common complication of insulin injection that has not been studied yet in children with type 1 diabetes mellitus (T1DM) in Isfahan.
Objectives: This study aimed to evaluate the prevalence of insulin injection-induced lipodystrophy based on related risk factors in children and adolescents with T1DM.
Methods: In this cross-sectional study, children and adolescents aged less than 18 years with T1DM who referred to the endocrinology clinic of Imam Hossein Hospital in Isfahan, Iran, in 2019 were enrolled. The baseline, anthropometric, and T1DM-related characteristics of the patients were recorded. Lipodystrophy was diagnosed by clinical examination. The characteristics of patients with and without lipodystrophy were compared. The association between lipodystrophy and disease-related factors was investigated.
Results: In this study, 194 patients with T1DM (88 boys and 106 girls) aged 3 to 18 years were evaluated. Lipodystrophy was diagnosed in 91 patients (46.9%), of which 64 patients (33%) had grade 1, 24 patients (12.4%) had grade 2, and 3 patients (1.5%) had grade 3 lipodystrophy. There was a significant difference in the frequency of lipodystrophy based on age, BMI, patient education, parent education, insulin injection site, duration of diabetes, injection site change, needle change, insulin dose, HbA1c, and hypoglycemia (P<0.05). Regression analysis indicated that there is a significant association between the presence of lipodystrophy and HbA1c (P<0.001, t=7.20), insulin dose (P<0.001, t=4.47), BMI (P<0.001, t=3.78) and duration of T1DM (P=0.002, t=3.15).
Conclusion: In this study, we reported a high prevalence of lipodystrophy among T1DM patients in Isfahan. From the studied risk factors, duration of diabetes, lower BMI, using a high dose of insulin, and uncontrolled diabetes (HbA1c>7) were the most important risk factors for lipodystrophy.
Objectives: This study aimed to evaluate the prevalence of insulin injection-induced lipodystrophy based on related risk factors in children and adolescents with T1DM.
Methods: In this cross-sectional study, children and adolescents aged less than 18 years with T1DM who referred to the endocrinology clinic of Imam Hossein Hospital in Isfahan, Iran, in 2019 were enrolled. The baseline, anthropometric, and T1DM-related characteristics of the patients were recorded. Lipodystrophy was diagnosed by clinical examination. The characteristics of patients with and without lipodystrophy were compared. The association between lipodystrophy and disease-related factors was investigated.
Results: In this study, 194 patients with T1DM (88 boys and 106 girls) aged 3 to 18 years were evaluated. Lipodystrophy was diagnosed in 91 patients (46.9%), of which 64 patients (33%) had grade 1, 24 patients (12.4%) had grade 2, and 3 patients (1.5%) had grade 3 lipodystrophy. There was a significant difference in the frequency of lipodystrophy based on age, BMI, patient education, parent education, insulin injection site, duration of diabetes, injection site change, needle change, insulin dose, HbA1c, and hypoglycemia (P<0.05). Regression analysis indicated that there is a significant association between the presence of lipodystrophy and HbA1c (P<0.001, t=7.20), insulin dose (P<0.001, t=4.47), BMI (P<0.001, t=3.78) and duration of T1DM (P=0.002, t=3.15).
Conclusion: In this study, we reported a high prevalence of lipodystrophy among T1DM patients in Isfahan. From the studied risk factors, duration of diabetes, lower BMI, using a high dose of insulin, and uncontrolled diabetes (HbA1c>7) were the most important risk factors for lipodystrophy.
Type of Study: Original Article |
Subject:
Pediatric Endocrinology
Received: 2021/10/26 | Accepted: 2021/11/27 | Published: 2022/12/19
Received: 2021/10/26 | Accepted: 2021/11/27 | Published: 2022/12/19
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Copyright © The Author(s);
This is an open access article distributed under the terms of the Creative Commons Attribution License (CC-By-NC),
which permits use, distribution, and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Contact Information
